Tested Applications
| Positive WB detected in | rat brain tissue, mouse brain tissue, mouse testis tissue, mouse kidney tissue |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
20200-1-AP targets ZNRF2-Specific in WB, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human, mouse, rat |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
Peptide Predict reactive species |
| Full Name | zinc and ring finger 2 |
| Calculated Molecular Weight | 24 kDa |
| Observed Molecular Weight | 30-35 kDa |
| GenBank Accession Number | NM_147128 |
| Gene Symbol | ZNRF2 |
| Gene ID (NCBI) | 223082 |
| RRID | AB_2878657 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q8NHG8 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
ZNRF2 also named as RNF202, may play a role in the establisment and maintenance of neuronal transmission and plasticity via its ubiquitin ligase activity. E3 ubiquitin ligases accept ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfer the ubiquitin to targeted substrates. The antibody is specific to ZNRF2.
Protocols
| Product Specific Protocols | |
|---|---|
| WB protocol for ZNRF2-Specific antibody 20200-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The ZNRF2 antibody (Cat# 20200-1-AP) has 4 total citations published in Molecular Neurobiology, Experimental Neurology, Journal of Cellular and Molecular Medicine, and Human Cell. The research fields span neurodegenerative disease (Parkinson's disease and mTOR-mediated neuroinflammation), stroke (cerebral ischemia/reperfusion injury), and oncology (pancancer analysis of ZNRF2 as an oncogene, and its role in breast cancer). All citations used the antibody for Western blot applications across mouse, rat, and human species.
| Species | Application | Title |
|---|---|---|
Mol Neurobiol Deletion of ZNRF2 Exacerbates MPTP-Induced Parkinson's Disease by Activating mTOR-Mediated Neuroinflammatory Pathways | ||
Exp Neurol ZNRF2 attenuates focal cerebral ischemia/reperfusion injury in rats by inhibiting mTORC1-mediated autophagy. | ||
J Cell Mol Med A pancancer analysis of the oncogenic role of ZNRF2 in human tumours
| ||
Hum Cell ZNRF2 as an oncogene is transcriptionally regulated by CREB1 in breast cancer models |









